Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Consumption Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesReliance Industries Limited10.230919729528.0336
Domestic EquitiesMarico Limited9.030334536924.7440
Domestic EquitiesITC Limited8.718157142923.8886
Domestic EquitiesVentive Hospitality Limited8.660730595123.7311
Domestic EquitiesZydus Wellness Ltd8.091611373722.1719
Domestic EquitiesMedplus Health Services Limited7.340420812720.1134
Domestic EquitiesStanley Lifestyles Limited5.759446954315.7813
Domestic EquitiesAditya Birla Lifestyle Brands Limited5.518888459915.1222
Domestic EquitiesSuraksha Diagnostic Limited5.031542936213.7868
Domestic EquitiesUNITED BREWERIES LIMITED4.68026487312.8241
Domestic EquitiesBajaj Auto Limited2.898092267.9408
Domestic EquitiesProcter & Gamble Hygiene & Health Care Limited2.839657287.7809
Domestic EquitiesAurobindo Pharma Limited2.4426583126.6931
Domestic EquitiesBata India Ltd0.8042174372.2037
Domestic EquitiesColgate-Palmolive (India) Ltd0.788287942.1597
Domestic EquitiesAditya Birla Fashion And Retail Ltd0.2907927880.7966
Total 83.1254 227.7718
Cash & Cash Equivalents and Net AssetsTREPS 02-Jun-2025 DEPO 1010.89912987429.8647
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-11.5898 -31.7573
Total -0.6907 -1.8926
Treasury Bills91 Days Treasury Bill 12-Jun-20252.91418000007.9850
Treasury Bills91 Days Treasury Bill 19-Jun-20251.09163000002.9910
Treasury Bills91 Days Treasury Bill 05-Jun-20250.72932000001.9984
Treasury Bills91 Days Treasury Bill 17-Jul-20250.72472000001.9857
Treasury Bills91 Days Treasury Bill 21-Aug-20250.72082000001.9752
Total 6.1805 16.9353
Derivatives-FuturesColgate-Palmolive (India) Ltd 26/06/20258.52029450023.3462
Derivatives-FuturesBajaj Auto Limited 26/06/20252.679184757.3410
Derivatives-FuturesAurobindo Pharma Limited 26/06/20250.185544000.5083
Total 11.3848 31.1955
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.